RecruitingNCT01257269
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Studying Congenital thrombotic thrombocytopenic purpura
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Principal Investigator
- Johanna A Kremer Hovinga, MDUniversity Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital
- Intervention
- Observation(other)
- Enrollment
- 450 enrolled
- Eligibility
- All sexes
- Timeline
- 2006 – 2030
Study locations (7)
- University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901, Oklahoma City, Oklahoma, United States
- Medical University of Vienna, Department of Medicine 1, Div. Hematology and Hemostasis Waehringer Guertel 18-20, Vienna, Austria
- Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U nemocnice 1, Prague, Czechia
- University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistr 52, Hamburg, Germany
- Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-cho 840, Kashihara, Nara, Japan
- Trondheim University St Olavs Hospital, Department of Hematology, PO Box 3250 Sluppen, Trondheim, Norway
- University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital, Bern, Switzerland
Collaborators
Swiss National Science Foundation · Mach Gaensslen Foundation · Baxalta Innovations GmbH, Wien, Austria
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01257269 on ClinicalTrials.govOther trials for Congenital thrombotic thrombocytopenic purpura
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07513948Daratumumab in Immune-mediated Thrombotic Thrombocytopenic PurpuraFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGNCT06441578A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraTakeda
See all trials for Congenital thrombotic thrombocytopenic purpura →